Modulation of the endocannabinoid and oxytocinergic systems as a potential treatment approach for social anxiety disorder (2019)
- Authors:
- USP affiliated authors: OSORIO, FLAVIA DE LIMA - FMRP ; ZUARDI, ANTONIO WALDO - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; SANTOS, RAFAEL GUIMARÃES DOS - FMRP
- Unidade: FMRP
- DOI: 10.1007/s40263-019-00669-5
- Subjects: TRANSTORNOS DA ANSIEDADE; ANSIEDADE SOCIAL; CANABINOIDES
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
DOS SANTOS, Rafael Guimarães dos et al. Modulation of the endocannabinoid and oxytocinergic systems as a potential treatment approach for social anxiety disorder. CNS Drugs, v. 33, n. 10, p. 1031-1038, 2019Tradução . . Disponível em: https://doi.org/10.1007/s40263-019-00669-5. Acesso em: 01 abr. 2026. -
APA
Dos Santos, R. G. dos, Osório, F. de L., Martin-Santos, R., Zuardi, A. W., Hallak, J. E. C., & Crippa, J. A. de S. (2019). Modulation of the endocannabinoid and oxytocinergic systems as a potential treatment approach for social anxiety disorder. CNS Drugs, 33( 10), 1031-1038. doi:10.1007/s40263-019-00669-5 -
NLM
Dos Santos RG dos, Osório F de L, Martin-Santos R, Zuardi AW, Hallak JEC, Crippa JA de S. Modulation of the endocannabinoid and oxytocinergic systems as a potential treatment approach for social anxiety disorder [Internet]. CNS Drugs. 2019 ; 33( 10): 1031-1038.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1007/s40263-019-00669-5 -
Vancouver
Dos Santos RG dos, Osório F de L, Martin-Santos R, Zuardi AW, Hallak JEC, Crippa JA de S. Modulation of the endocannabinoid and oxytocinergic systems as a potential treatment approach for social anxiety disorder [Internet]. CNS Drugs. 2019 ; 33( 10): 1031-1038.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1007/s40263-019-00669-5 - Cannabidiol for the treatment of epilepsy: an overview of possible mechanisms of action and preclinical and human studies
- Cannabidiol for the treatment of drug use disorders
- Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
- Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial
- Neuropharmacological effects of the main phytocannabinoids: a narrative review
- O uso do canabidiol (CBD) no tratamento da doença de Parkinson e suas comorbidades
- We have read with great interest the report by .... [Carta]
- Anxiety, panic, and hopelessness during and after ritual ayahuasca intake in a woman with generalized anxiety disorder: a case report
- Classical hallucinogens and neuroimaging: a systematic review of human studies studies : hallucinogens and neuroimaging
- Study finds ayahuasca administration associated with antidepressant effects
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
